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This issue brief, originally published in June 2002, was first updated 
in August 2003 to reflect recent activities relating to the trade dis-
pute between the U.S. and the European Union (EU) on genetically 
modified food. This edition represents the third update.
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I. INTRODUCTION & SUMMARY
Over the last ten years, U.S. farmers have planted millions of acres of genetically-
modified varieties of corn, cotton, and soybeans. In 2004, about 45% of the corn, 
85% of soybeans, and 76% of cotton planted in the U.S. were genetically modified 
varieties.1 Since much of the corn and soybeans harvested each year are processed 
into products like corn oil and lecithin, it is not surprising that an estimated 75% of 
processed food sold in the United States contains ingredients derived from geneti-
cally modified (GM) crops.
In the United States, the introduction of GM foods—foods derived from GM crops or 
containing ingredients derived from GM crops—has not elicited strong public con-
cern or widespread opposition. Indeed, most Americans are unaware of the extent to 
which genetically modified foods have been introduced into the marketplace.2 
Europe, however, is a different matter. With public confidence in food safety shaken 
by a series of food scares unrelated to GM foods, including a serious outbreak of 
mad cow disease or bovine spongiform encephalopathy (BSE), European consumers 
are wary about GM foods. European Union (EU) member states grow few GM crops, 
and very few (if any) foods carrying the required GM label appear to be available 
for sale in the EU marketplace. Faced with popular opposition to GM foods and a 
concern about an inadequate regulatory system, the European Commission failed to 
approve any new GM foods or crops between 1998 and 2004, despite general scien-
tific consensus that they posed no food safety or environmental risks. In 2004, new 
EU laws went into effect providing for the approval of GM crops, as well as GM 
food and feed, and establishing new requirements for labeling and traceability. 
Since then, the Commission has moved through a lengthy process to approve several 
GM crops and food and feeds derived from GM crops. In June 2005, however, a 
1  See PIFB, Genetically Modified Crops in the United States (http://pewagbiotech.org/resources/fact-
sheets/display.php3?FactsheetID=2)
2  See PIFB, Public Sentiment about Genetically Modified Food Update November 2004 http://pewagbio-
tech.org/research/2004update/ 
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qualified majority of the Council of Ministers refused to lift certain EU member state 
bans on GM products that had been approved by the Commission, creating new 
doubts about the viability of an EU-wide policy on GM crops, food and feed.
Export markets remain a critical source of revenue for U.S. farmers. EU opposition 
to GM food has harmed U.S. exports, particularly corn shipments which typically 
include GM varieties not approved by the EU. Charging that the EU failure to 
approve GM crops during the de facto moratorium of 1988 to 2004 was without a 
scientific basis and therefore inconsistent with the Agreement on the Application of 
Sanitary and Phytosanitary Measures, the U.S. initiated an unfair trade practices 
complaint in the World Trade Organization (WTO) in May 2003. A preliminary  
decision from the trade dispute panel is expected in January 2006.
In addition, the U.S. reportedly has been considering a second WTO complaint that 
would challenge the new EU requirements for traceability and labeling. These mea-
sures have also been attacked by U.S. officials and agricultural industry representa-
tives as unnecessary and unworkable, while EU officials have defended them as 
non-discriminatory and necessary to rebuild consumer confidence in the EU food 
safety regulatory system and in GM foods generally.
This issue brief provides an overview of the history of the dispute between the U.S. 
and the EU over GM foods and crops, the impacts of the dispute on U.S. trade, and a 
summary of current EU regulations and its approval process. The Appendices pro-
vide additional background on other on-going international negotiations that may 
also affect trade in GM crops, as well as information about the evolving structure of 
EU governance. 
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II.  BACKGROUND:  
U.S. – EU TRADE
Looking at goods and services combined, the EU and U.S. are each other’s main 
trading partners and account for the largest bilateral trade relationship in the world. 
The recent accession in 2004 of 10 new member states3 into the EU increases the 
importance of the EU both as an export market, a global economic competitor, and 
as a source of imported goods and services. (For general information on the EU and 
its institutions see Appendix E: Backgrounder on the EU.) 
The EU is the fourth largest market for U.S. agricultural exports. According to U.S. 
Department of Agriculture (USDA), agricultural exports from the U.S. to the EU are 
projected at $7 billion for 2005, nearly 12% of all U.S. agricultural exports. The 
main export products are soybeans, tobacco, and animal feed, including corn glu-
ten. (For more detail see Appendix B: Details on U.S. Agricultural Trade with the 
EU 1998–2004.)
The U.S. also is a major importer of EU agricultural and horticultural products, 
including cheese, oils, wine and beer. USDA projects 2005 agricultural imports from 
the EU to the U.S. at $13 billion. 
Exports are a critical source of revenue for U.S. producers of commodity crops. In 
2002, according to USDA estimates, exports of crops accounted for over one-quarter 
of the total value of U.S. crop production. In terms of volume and farm income, the 
most important field crops grown in the U.S. are corn, cotton, and soybeans. They 
are essential in the production of human food and animal feed and are also the 
source of many ingredients used extensively in processed foods, such as high fruc-
tose corn syrup. 
Prior to 1997, corn exports to Europe represented about 4% of total U.S. corn 
exports, generating about $300 million in sales. Starting in 1997, however, the U.S. 
largely stopped shipping bulk commodity corn to the EU because such shipments 
typically commingled corn from many farms, including genetically modified variet-
ies not approved by the EU. The change was dramatic. For example, before 1997, 
the U.S. sold about 1.75 million tons of corn annually to Spain and Portugal, the 
two largest importers of U.S. corn in the EU. But in the 1998–99 crop year, Spain 
bought less than a tenth of the previous year’s amount and Portugal bought none at 
3  The ten new member states are: Cyprus, Czech Republic, Estonia, Hungary, Latvia, Lithuania, Malta, 
Poland, Slovakia, and Slovenia.
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UNITED STATES CORN EXPORTS
CUMULATIVE VALUES IN US $1,000  •  JANUARY–DECEMBER 2004
North America 15%
Asia 54%
Africa 11%South America 6%
Caribbean 3%
Central America 5% Middle East 6%
Other Europe >1%
EU-25 >1%
Oceania >1%
Former Soviet Union >1%
all. By 2004, the EU share of the total corn export market had fallen to less than 0.1 
percent. (See Appendix B: Details on U.S. Agriculture Trade with the EU 1998–
2004 and figure below.)
Some commodity crop exports have not been affected directly by the ban on some 
GM varieties. For example, Europe remains the most important U.S. export market 
for corn byproducts, such as the corn gluten used in animal feed, accounting for 
more than 54 percent of total exports in 2004. The trade of corn byproducts thus far 
has not been affected by EU regulations on GM products.4 
4  In March, 2005, Syngenta announced that it had inadvertently distributed small amounts of an unau-
thorized GM corn (Bt10) over a 4-year period. U.S. regulatory authorities stated that the unauthorized 
GM corn posed no safety risk because it contained the same GM protein that was in BT11, a GM variety 
approved both in the U.S. and in Europe for food. However, the Bt10 variety also included an antibiotic 
resistance marker gene which, while unlikely to create a food safety problem, had not been approved in 
the EU. As a result, the Commission temporarily suspended shipments of corn imports, including corn 
gluten, until the development of a test protocol to determine the presence of Bt10. As of May 2005, test-
ing was available and corn shipments resumed. 
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UNITED STATES SOYBEAN EXPORTS
CUMULATIVE VALUES IN US $1,000  •  JANUARY–DECEMBER 2004
North America 14%
Asia 66%
Africa 1%South America >1%
Caribbean >1%
Central America 1% Middle East 3%
Other Europe >1%
EU-25 11.7%
Oceania >1%
Former Soviet Union >1%
Similarly, GM soybean exports to the EU have not been affected by the de facto 
moratorium. The EU had approved one variety of GM soybean prior to 1998. 
Because the EU market accounts for a significant proportion (11.7% in 2004) of U.S. 
soybean exports, American soybean producers have been reluctant to introduce new 
biotech varieties that have not been approved for the European market. While U.S. 
soybean exports to the EU have fallen (from 9.8 million tons in 1995 to 3.6 million 
tons in 2004), the decline is more likely due to increased competition from lower-
cost agricultural producers such as Brazil, whose exports have risen from 3.0 mil-
lion tons in 1995 to 8.9 million tons in 2002.5
5  USDA Economic Research Service, “Briefing Room: Soybeans and Oil Crops: Trade” www.ers.usda.gov/
briefing/soybeansoilcrops/trade.htm. 
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III. THE EUROPEAN EXPERIENCE  
WITH GM FOODS
A. European Attitudes toward GM Crops and Foods 
In 1996, then U.S. Agriculture Secretary Dan Glickman got an early glimpse of the 
unfolding controversy over GM foods in Europe when protesters at the World Food 
Summit in Rome pelted him with grain, calling for a ban on GM crops. (For a time-
line of critical events, see Appendix D: Timeline of events relevant to U.S.–EU agri-
cultural biotechnology trade issues.) 
European attitudes toward GM crops and food have been shaped by a variety of 
factors, including the experience of a major food safety crisis (mad cow disease), the 
lack of confidence in food regulators, different cultural attitudes toward food and 
farms, widespread media coverage of the issue, and activism by politically influen-
tial environmental, consumer and anti-globalization groups.
European public opinion surveys show strong opposition to GM crops and foods. 
An EU-wide study in 2002 found that while attitudes varied among nations, majori-
ties in most EU countries rejected GM foods, which were seen as “risky” and “not 
useful” for society.6 In the different EU countries, between 30% and 65% percent 
rejected all the reasons for buying GM foods. Countries with the highest percentage 
of those rejecting GM foods were Greece, Ireland and France, and those with the 
lowest percentage rejecting GM foods were the UK, Austria and Finland. While the 
2002 Eurobarometer poll also suggests that opposition to GM crops and foods had 
waned in recent years, significant majorities in most countries continued to oppose 
them. More recently, a 2005 Eurobarometer poll showed that safety concerns about 
GM food persist in Europe, although opinion again differs by nation as well as other 
demographic factors.7 Over two-thirds of those polled in Austria, Cyprus, and 
Greece agreed with the statement that foods made from GMOs were “dangerous”, 
but even in more supportive countries such as the Netherlands and the United 
Kingdom, nearly one-third agreed with that statement. 
6  Eurobarometer 58.0 Europeans and Biotechnology in 2002. http://europa.eu.int/comm/public_opinion/
archives/ebs/ebs_177_en.pdf
7  Special Eurobarometer 224, “Europeans, Science & Technology”, 2005. http://Europa.eu.int/comm/ 
public_opinion/archives/ebs/ebs_224_report_en.pdf
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B. Food Safety Crises
Negative public opinion about GM crops and foods is largely the product of several 
widely-publicized food safety scares in the mid-1990s that have made European 
consumers extremely wary of changes to the food supply and distrustful of govern-
ment regulatory agencies. Although these crises were not caused by GM food, GM 
food has been caught up in the general concern about food safety. 
The most significant of these food crises was “mad cow disease,” or bovine spongi-
form encephalopathy (BSE), which was discovered in the U.K. in the 1990s before 
being found in other countries. BSE is an infectious degenerative brain disease in 
cows. It is believed that the infectious agent was introduced to cows in the U.K. 
through feed that contained parts of sheep brains that were infected with scrapie. 
(The infectious mechanism of BSE is still not entirely understood.) 
Originally, food safety authorities in the U.K. asserted that BSE posed no food safety 
threat to humans, and that it could not be transmitted to human beings if they ate 
meat from infected animals. In 1996, however, scientists discovered a link between 
some cases of a fatal degenerative brain disease in humans (called Creutzfeldt–Jacob 
disease, or CJD) and consumption of meat from cows infected with BSE. Initially, 
government officials dismissed the research and minimized the link between BSE 
and its human form. But later, British officials were forced to recognize the link and 
take drastic steps to protect human and animal health, including the destruction of 
4.5 million cattle to prevent the spread of the disease. Despite these measures, the 
government was harshly criticized for acting too late and not effectively communi-
cating risks to the public. 
The impact on the beef market—and on public opinion—was dramatic. The British 
beef market was crippled. Throughout Europe, fears about CJD and pictures of thou-
sands of sick cattle being incinerated dominated news, particularly when BSE was 
discovered in other European countries. 
Public concern was escalated by early estimates that suggested as many as 100,000 
people would die from CJD in the UK. While those estimates are now believed to be 
far too high, there remains significant uncertainty about the eventual toll BSE will 
have on human health. As of 2005, 149 deaths in the UK have been caused by CJD.8
8  Data from CJD surveillance program at the University of Edinburgh, http://www.cjd.ed.ac.uk
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Combined with several later highly publicized food and agricultural crises, including 
dioxin-tainted meat in Belgium and foot-and-mouth disease outbreaks all over 
Europe, the BSE debacle dramatically eroded trust in government food safety regula-
tors. In the 2002 Eurobarometer poll, only 14 percent of Europeans polled said that 
they trusted national governmental bodies to “tell the truth” about biotechnology. 
GM crops began to be introduced to the European market in 1996, the same year 
when the BSE crisis began unfolding. Governmental and scientific authorities, par-
ticularly in Britain, strongly endorsed the safety of agricultural biotechnology. To 
many, these assurances were all too reminiscent of those given for BSE-infected 
meat. The European press extensively covered environmental and consumer groups 
and scientific critics who warned about unknown food safety and environmental 
risks of GM crops and foods. The concerns quickly caught the attention of wary 
European consumers who trusted NGOs more than the government. In the 2002 
Eurobarometer public opinion survey, the two institutions most likely to be trusted 
to “tell the truth” about biotechnology, after medical doctors (54%), were consumer 
organizations (49%) and environmental organizations (46%).
C. Cultural attitudes and other issues
Concerns about food safety are not the only factor influencing European public 
opinion about GM crops and foods. Historically, Europeans seem to have a deeper 
cultural connection to their food than do most Americans. Most European countries 
have cuisines based on traditional foods connected with regional and even local 
production practices. Supermarkets have not entirely replaced the local, specialized 
food producers—bakers, butchers, and neighborhood produce stands. In contrast, 
most urban American consumers have little connection with the food production 
process, and most products are marketed and shipped nationwide, often with an 
emphasis on novelty, consistency and convenience. 
In addition to these cultural differences, the European public appears to be more 
sympathetic than Americans to the perception that biotechnology is unnatural or 
even unethical. Britain’s Prince Charles reflected some of this concern when he stat-
ed that the development of genetically modified foods “takes mankind into realms 
that belong to God, and to God alone.” 
Europeans are also skeptical about the value of GM crops and foods for European 
consumers and farmers. To many Europeans, GM crops produced to date may be 
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valuable to U.S. farmers and multinational seed companies, but have no direct con-
sumer benefit, such as added nutritional value or improved taste.9 
D. European Regulation of GM Crops and Foods Prior to 1998
Prior to 1998, the EU had adopted two sets of EU-wide laws relating to GMOs and 
GM food and feed. The first, Directive 90/220/EC, adopted in 1990, established a 
process for the assessment and approval of all GM organisms (including GM crops 
and seeds) before they were deliberately released into the environment, such as for 
field trials or commercial cultivation. Before the outbreak of the BSE crisis and the 
ensuing controversy over food safety, a number of GM crops were approved under 
Directive 90/220/EC, some for restricted uses. Prior to 1998, fourteen GM plants, 
including 11 crops, had been approved for some form of release. (See Appendix F: 
Status of GMOs in the EU.) An additional thirteen applications for approval had 
received favorable opinions from the Scientific Committee on Plants and were 
pending authorization in 1998.
A second set of laws, Regulation (EC) No 258/1997, or the “Regulation on Novel 
Foods and Novel Food Ingredients” was adopted in 1997 and addressed GM food 
safety issues. The Novel Foods regulation required the labeling of novel food prod-
ucts containing or consisting of genetically modified ingredients, or which had been 
produced from GMOs. Regulation 258/97/EC also created a more simplified approval 
procedure for food products that are “derived from GMOs” but do not contain 
GMOs, such as highly refined soy oil or corn syrup. A food “derived from GMOs” 
could be brought to the market as long as the developer had a scientific basis for 
determining that the product was “substantially equivalent” to existing foods, noti-
fied the Commission, and delivered an opinion to the same effect from competent 
authorities of a Member State. Under the Novel Food regulation, a number of prod-
ucts derived from GM crops, including oils and products that use oils, entered into 
the EU market. (See Appendix F: Status of GMOs in the EU.)
9  Comments of Tony Van der haegan, Minister-Counselor for Agriculture, Fisheries, and Consumer Affairs 
of the European Commission, PIFB, Are the U.S. and EU Headed for a Food Fight over Genetically Modified 
Food?, Policy Forum at the National Press Club, October 24, 2001 (http://pewagbiotech.org/
events/1024/).
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IV. THE DE FACTO  
MORATORIUM ON GMOS
A. EU–wide approval process falls apart
These EU-level efforts in the 1990s were an attempt to develop a uniform EU-wide 
policy for approvals and trade in GM crops and foods, which was growing increas-
ingly controversial in a number of member states in the mid and late 1990s. 
Widespread media coverage of anti-GM activists helped move the issue of GM foods 
quickly to the forefront of political debate in Europe. Increased representation of the 
Green Party in member state parliaments and cabinets, as well as in the European 
Parliament, ensured that these concerns would be reflected in national and 
European politics. Almost overnight, GMOs became politically unpopular and politi-
cians found it difficult to approve GM crops and foods despite scientific reviews 
that failed to raise safety concerns. (For details on the EU regulatory system and 
legislative process see Appendix E: Backgrounder on the EU.) 
By 1997, the effort to craft a uniform EU-wide policy on GMOs was coming apart. 
Despite EU approvals for commercialization of several GM crops under Directive 
90/220/EEC, a number of member states invoked a “safeguard clause” to ban the use 
of the approved GM crops in their respective countries. (The “safeguard clause” is 
discussed below.) In 1997, Austria and Luxembourg banned several EU-approved 
GM crops. Over the next several years, additional bans on EU-approved crops fol-
lowed in Austria, Italy, Greece and Germany. While the Commission could have 
taken legal action to force compliance, it chose not to do so at that time.
In 1998, a number of EU member states, led by France, vowed to block approval of 
GM crops unless existing labeling and safety regulations were further tightened. As 
a result, no new GM foods or crops were approved beginning in 1998 through 2004, 
constituting a de facto moratorium on GMO approvals while the EU was working to 
develop new EU-wide legislation more acceptable to the member states.
B. The U.S. Responds with a WTO trade complaint
U.S. farm organizations, biotechnology companies, and other companies in the food 
production and processing chain, strongly objected to the EU de facto moratorium, 
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as well as its failure to take action against some member states that banned GM 
crops that had been approved by the Commission. Objections were also strongly 
voiced by U.S. government officials in both the Clinton and Bush administrations. 
U.S. officials argued that the de facto moratorium and the EU’s failure to enforce its 
own trade rules violated free trade agreements, particularly the Agreement on the 
Application of Sanitary and Phytosanitary Measures (SPS), and the Agreement on 
Technical Barriers to Trade (TBT). Under those agreements, U.S. officials argued, the 
EU cannot raise barriers to trade in crops and food for safety concerns without a 
scientific basis, which the U.S. believed was entirely lacking. 
EU officials responded that a delay was necessary while they were developing new 
legislation for GM food and feed approvals that would be more acceptable to mem-
ber states and that the approval process would start up when new legislation was 
in place.
In May 2003, the U.S., along with Canada and Argentina, launched a formal com-
plaint using the World Trade Organization’s dispute settlement mechanism, arguing 
that the de facto moratorium was not in compliance with WTO agreements. Under 
WTO rules, if a member does not comply with WTO recommendations, then trade 
sanctions may follow. A preliminary decision by the Dispute Settlement Body has 
been expected several times. It is now expected in January 2006. (For details on the 
dispute process see Appendix C: The WTO Trade Dispute Process.)
Some have questioned the ultimate effect of the trade complaint, noting that the 
action is likely to generate additional hostility to GM foods in Europe and that the 
EU has begun approving new GM foods under new laws adopted in 2003, discussed 
below.10 However, U.S. farm and industry officials have strongly expressed the view 
that the EU de facto moratorium is an illegal restraint on trade because it is a viola-
tion of the EU’s own trade rules and procedures. In addition, they believe that GM 
crops and foods are as safe as conventional foods and that there is no scientific 
basis for health or safety restrictions. This sentiment was echoed by the Canadian 
trade representatives in their June 2004 argument in the first round of arbitration 
that [the EU] ``has maintained its moratorium even in the face of the uncontrovert-
ed opinions of its own scientists that there is sufficient evidence to reach conclu-
sions about the safety of these products.’’11 
10 PIFB, Should the U.S. Press A WTO Case Against Europe’s Genetically Modified Food Policies?, Policy Forum 
at the National Press Club, February 2003 policy dialogue, http://pewagbiotech.org/events/0213
11 “U.S., Canada, Ask WTO to Force Open EU’s Biotech Seed Market”, Bloomberg. June 4, 2004
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U.S. officials also believe that a challenge is necessary to discourage other countries, 
especially those in the developing world, from using the EU regulatory approach as 
the basis for their own regulations on agricultural biotechnology products, which 
could result in even wider-scale disruptions of U.S. trade. President Bush is con-
cerned that stringent EU restrictions have led to the refusal of several south African 
nations to accept U.S. food aid that included GM corn, further exacerbating famine, 
a charge that EU officials vehemently reject.
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V.  EU ADOPTS NEW  
LEGISLATION ON GMOS
A. New EU Legislation
In 2003, the EU approved new legislation governing approval of GM food and feed 
for commercialization and requiring labeling and traceability. It went into effect in 
April 2004. The EU legislation expanded the existing labeling requirements signifi-
cantly and also required “traceability”—the ability to track a GM product from the 
farm through all of the distribution, processing, and manufacturing steps to the 
final consumer product. The legislation also established a more streamlined, central-
ized authorization procedure for GM crops and GM food ingredients and their 
release in the environment and in the marketplace. 
LABELING. Under Regulation (EC) 1830/2003, all food and feed consisting of GMOs 
or produced from GMOs are required to be labeled. Products required to be labeled, 
must state that “This product contains genetically modified organisms” or that it has 
been “produced from genetically modified (name of organism).” For the first time, 
refined products, like soy oil or high fructose corn syrup, are required to be labeled, 
even in the absence of any detectable amounts of GM DNA or proteins because they 
are “produced from” GMOs. The accidental and unavoidable presence (up to 0.9%) 
of GM material in food is exempted from the labeling obligation. The regulations 
also require animal feed to be labeled along the same principles as for GM food, but 
do not require labeling of products such as meat, milk or eggs obtained from ani-
mals fed GM feed or treated with GM medicinal products. Products such as cheese 
or beer, which are often produced with the aid of enzymes produced by GM micro-
organisms, also do not need to be labeled. According to Commission officials, this 
distinction was made to be consistent with existing EU law that does not require 
labeling of any enzyme used as a processing aid. 
According to the European Commission, more extensive labeling information is 
meant to help restore consumer confidence in the food regulatory system, to pro-
vide consumers with greater choice about what they eat, and build consumer confi-
dence in GM products.
TRACEABILITY. The EU legislation also requires businesses that grow, store, transport, 
or process GM products to track them throughout the commercial food chain, from 
“farm to fork.” Under these rules, industry must ensure that systems are in place to 
14
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identify to whom and from whom GM products are made available and to retain 
records for five years. All foods require documentation demonstrating whether they 
contained ingredients derived from GM crops, even if the presence of GM-derived 
material can not be detected in the final product. 
According to the European Commission, the objectives for requiring traceability of 
GM products are to facilitate the withdrawal of a product in the event of an unfore-
seen risk to human health or the environment, to aid in the monitoring for potential 
health or environmental effects, and to control and verify labeling claims.
APPROVAL. Regulation (EC) 1829/2003 establishes a “one door–one key” procedure 
for GM food and feed by which a developer may file a single application for all 
intended uses of the GMO—cultivation, importation, and processing. An application 
first goes to a member state where the product is requested to be marketed. A scien-
tific risk assessment is then carried out by a single agency—the European Food 
Safety Authority (EFSA). Following the risk assessment by the EFSA, the 
Commission drafts a proposal for granting or denying the authorization; if it dis-
agrees with the EFSA opinion, it must justify its position. 
The Commission’s draft proposal is submitted for approval by a qualified majority of 
the member states within the Committee on the Food Chain and Animal Health. If 
the Committee approves it, the Commission then adopts the decision. If not, the draft 
decision is submitted to the Council of Ministers for adoption or rejection by quali-
fied majority. If the Council fails to act, or fails to muster a qualified majority to 
accept or reject the proposal, the Commission then adopts the decision. (For a discus-
sion of the “qualified majority vote”, see Appendix E: Backgrounder on the EU.) 
According to the European Commission, the risk assessment and approval process is 
intended to streamline the approval process and to pave the way for the approval of 
new GM crops stalled under the former regulatory approach. 
B. Experience under the new EU system
LABELING. The EU’s new laws went into effect in April 2004. More than a year later, 
few, if any, consumer products in the EU market appear to be labeled as containing 
GMOs. Fearing negative consumer reaction from GM-labeled foods, food manufac-
turers have reportedly “reformulated” products with non-GM ingredients to avoid 
labeling. For example, a manufacturer could substitute sugar syrup made from 
U.S. vs. EU: AN EXAMINATION OF THE TRADE ISSUES SURROUNDING GENETICALLY MODIFIED FOOD
15
sugar cane or sugar beets, which are not genetically modified, for the corn syrup 
that comes from GM corn; alternatively, the manufacturer could source ingredients 
from non-GM sources. Further, some EU retailers appear to be wary about consumer 
reaction (and possible activist protests) from stocking GMO-labeled foods. 
APPROVALS. In May 2004, the Commission approved its first GM food under the new 
regulations and the first since 1998. The Commission approved the import of 
Syngenta’s GM canned sweet corn, under the labeling and traceability provisions of 
the new regulations. A few months later, in July 2004, the Commission also 
approved a Monsanto GM Roundup Ready maize variety (NK 603) for human and 
animal consumption, but not for planting. In August 2005, the Commission 
approved the import of Monsanto GM maize MON863 for animal feed, but not for 
cultivation or food use.
In each of these cases, the Commission acted to approve the applications after the 
Council failed to approve or reject the Commission’s proposed action by a qualified 
majority vote. 
APPLICATIONS. When Directive 2001/18/EC took effect, some of the pending applica-
tions from under the previous directive, Directive 90/220/EEC were withdrawn, 
while others were resubmitted, and other new applications were submitted for 
authorization. As of March 2005, twenty-four applications had been submitted for 
approval under Directive 2001/18/EC. These applications included eight varieties of 
maize, five varieties of oilseed rape, five varieties of cotton, three varieties of beets, 
one variety of potato, one variety of rice, and one variety of soybean. 
MEMBER STATE RESISTANCE. Despite the new EU legislation, GMOs remain unpopular 
in many parts of Europe and national politicians have acted to assert independence 
and autonomy over GM crops and foods. Five countries (Austria, France, Germany, 
Greece, Luxembourg) are currently blocking the use of five GMO varieties that had 
been previously approved by the Commission (three modified maize varieties and 
two types of oilseed rape) by invoking the “safeguard clause.”12 The “safeguard 
12 Austria, France, Germany, Greece, Luxembourg, and the UK initially invoked the “safeguard” clause that 
had previously appeared in the now-repealed Directive 90/220/EEC. In 2003, the Commission requested 
those states to reconsider their invocation in light of the new regulatory framework and if necessary to 
resubmit them under the safeguard clause now found in article 23 of Directive 2001/18/EEC. In 2004, 
Greece and Austria submitted further information in support of their bans but no response was received 
from the other member states. In July 2004, EFSA concluded that the additional information did not 
invalidate the original risk assessment. In January, 2005, Hungary also invoked the safeguard clause to 
ban the planting of MON810, a Bt corn variety; the Commission is currently examining the case. 
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clause” provides that a Member State may provisionally restrict or prohibit the use 
or sale of an approved GMO if there is “new or additional information … or scientific 
knowledge” that gives it “detailed grounds” that the GMO “constitutes a risk to 
human health or the environment.” The Commission and the EFSA reviewed the 
information provided by the member states to justify their bans, and in April 2005, 
the Commission called on those five nations to lift their national bans. 
In June 2005, however, the Commission recommendation to force the lifting of the 
national bans was rejected by a qualified majority of the Council, leaving the 
national bans in place. The rejection “raises a host of questions”, according to a 
Commission statement. “The Commission will have to carefully consider the legal 
and scientific bases that underpin any further proposals, as well as the implications 
for EU internal market and trading partners.” The Council’s decision leaves in doubt 
the ability of the Commission to create a uniform approval process through the EU, 
despite the new legislation.
In addition, politicians in Ireland, Wales, Austria, parts of France, and the Scottish 
Highlands have all petitioned their respective governments to create GM free zones, 
and to institute local bans on the cultivation of GM crops. In October, 2005, the 
EU’s second-highest court ruled that Austria’s ban of a GM crop was unlawful.
In the wake of these member state actions driven by popular opposition and politi-
cally powerful activist groups, the Commission clearly is continuing to struggle to 
implement a consistent and enforceable EU-wide policy on GM crops and food. The 
Commission faces the task of trying to manage the conflict between autonomous 
member states where GMOs are highly unpopular with the authority of the EU sys-
tem. Uncertainty has also been compounded by recent changes in the Commission 
membership.13
In addition to assessments and approvals for GMOs, another GM crop-related issue 
generating debate within the EU is the potential liability of GM crop growers or 
seed companies for the accidental “contamination” of non-GM crops. In the past, 
the EU has indicated that rules for “coexistence” should be left to the member states, 
but more recently there has been interest in adopting EU-wide policies.
13 New Commissioners were appointed to the European Commission in 2004 and will serve 5-year terms. 
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C. U.S. Reaction to new EU regulations on GMOs
U.S. government officials, farm groups, biotechnology companies, and food proces-
sors and manufacturers have expressed deep concern over the impacts of the new 
EU labeling and traceability requirements. They regard the EU rules as costly, 
unworkable, unenforceable, unnecessary and discriminatory against U.S. agricultur-
al products. The Administration is reportedly considering filing a second WTO com-
plaint against the new labeling and traceability requirements. U.S. farm groups and 
others are pushing for the U.S. to initiate such a challenge. The American Farm 
Bureau Federation has said that the labeling and traceability rules are “just as 
inconsistent with the WTO agreement on technical barriers to trade and sanitary 
and phytosanitary measures as the moratorium itself is.” 
U.S. farmers, food manufacturers and food and grain exporters have been working 
to comply with the EU regulations since they became effective in April 2004. In 
some instances, as noted above, foods with GMO ingredients have been reformulat-
ed to avoid the labeling requirement. Developing traceability and product identifica-
tion systems to ensure compliance with EU labeling, threshold, and traceability 
requirements has been challenging. The U.S. commodity grain system routinely 
mixes GM varieties in with conventional varieties of corn and soybeans. To avoid 
the EU threshold for labeling, U.S. farmers and food producers need to segregate 
GM crops and foods derived from such crops at every step of the production proces-
s—a costly requirement. Meeting the EU threshold of no more than 0.9 percent GM 
content is also difficult to achieve and equally difficult to test with consistency, cre-
ating uncertainty about liability despite efforts to comply. 
Although total costs of compliance are not available, such efforts have undoubtedly 
been costly for U.S. industry. Nevertheless, bulk commodity grain traders and others 
involved in the grain processing and distribution channel appear to be meeting the 
EU requirements. 
These requirements apply to food and feed that are intended to be marketed as non-
GM. However, unlike food, there is still active demand for GM feed in the EU. While 
GM feed itself must be labeled, meat, milk and eggs derived from animals fed with 
GM feed are not required to be labeled. As a result, some U.S. exports, such as soy 
and corn gluten intended for feed uses, do not need to be segregated since there 
continues to be an active EU market for GM-labeled feed. (Feed intended to be mar-
keted as GM-free would, of course, need to be segregated.)
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The Bush Administration believes that the EU labeling regime is both unnecessary 
and discriminatory. The U.S. argues that there is no scientific basis to treat GM food 
and feed any differently from food or feed produced through conventional breeding 
and that labeling and segregation requirements are based on politics, not science. 
Furthermore, labels that identify foods as derived from biotechnology are likely to 
be seen by consumers as “warning labels,” which would be misleading and decrease 
the demand for these products. U.S. officials point out that the EU rules do not 
require labeling of products like beer and cheese (major European agricultural 
exports) that are made using enzymes produced with biotechnology, while soy oil 
derived from GM soybeans would have to be labeled even if no GM protein could 
be detected. 
SOURCES 
Office of the United States Trade Representative 
United States Department of Agriculture 
Foreign Agriculture Service 
European Commission 
Congressional Research Service report, RS21556, “Agricultural Biotechnology:  
The U.S.-EU Dispute” updated March 16, 2004. 
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APPENDIX A
The International Regulation of Biotechnology and Its Trade
The main international body that regulates trade is the World Trade Organization 
(WTO). The U.S. Trade Representative (USTR) represents U.S. interests at WTO meet-
ings. Ambassador Allen Johnson of the USTR’s office oversees negotiations for the 
U.S. at the WTO on agricultural trade. World trade rules are currently governed by 
the last round of negotiations between WTO members, which took place in Uruguay 
in 1994. The WTO Agreement on the Application of Sanitary and Phytosanitary 
Measures and Agreement on Technical Barriers to Trade and the Trade Dispute 
Process are the mechanisms used for the resolution of issues on agricultural bio-
technology products. Negotiations currently taking place under the Doha 
Development Agenda will most likely also address biotechnology and agriculture. 
A number of entities within the United States government represent U.S. interests in 
organizations responsible for regulating international trade. Some of the agencies, 
primarily those within the U.S. Department of Agriculture (USDA), the Food and 
Drug Administration (FDA), and the Environmental Protection Agency (EPA), play a 
role in agricultural trade negotiations because of their regulatory expertise in plant 
and animal health, food safety, or environmental protection. Other agencies, such as 
the Office of the U.S. Trade Representatives (USTR), USDA’s Foreign Agricultural 
Service (USDA/FAS) and the U.S. Department of State are involved because of their 
responsibilities for trade, export facilitation, or diplomatic negotiations. 
The Codex Alimentarius Commission, an entity established by the World Health 
Organization (WHO) and the Food and Agriculture Organization (FAO) of the United 
Nations, is in the process of developing international guidelines for countries that 
choose to establish mandatory labeling of food and food ingredients obtained 
through biotechnology. In July 2003, the Commission adopted new proposed stan-
dards regarding risk analysis and guidelines for conducting safety risk assessments 
for foods derived from biotechnology. Both traceability and food labeling were 
named as risk management tools. 
The United Nations Convention on Biological Diversity14 developed an environmen-
tal agreement, the Cartagena Biosafety Protocol,15 covering the trans-shipment and 
14 The text of the United Nations Convention on Biodiversity may be found at http://www.biodiv.org . 
15 The text of the Cartagena Biosafety Protocol may be found at http://www.biodiv.org/biosafety. 
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use of living modified organisms (LMOs). The Biosafety Protocol became effective in 
September 2003. The U.S. Department of State represents U.S. interests at Biosafety 
Protocol negotiations. However, since the U.S. is not party to the United Nations 
Convention on Biological Diversity, U.S. participation is limited. 
The Organization for Economic Cooperation and Development, to which the United 
States and the European Union are parties, may also address agricultural biotech-
nology trade issues in the context of international harmonization of biotechnology 
regulations. OECD attempts to foster free trade and market economies through the 
development of consensus documents, information, and outreach. 
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APPENDIX B
Details on U.S. Agricultural Trade with the EU 1998–2004
CHART 2: U.S AGRICULTURAL EXPORTS TO THE EU-25 BY VOLUME IN METRIC TONS
1998
(in 1,000 
metric tons)
1999
(in 1,000 
metric tons)
2000
(in 1,000 
metric tons)
2001
(in 1,000 
metric tons)
2002
(in 1,000 
metric tons)
2003
(in 1,000 
metric tons)
2004
(in 1,000 
metric tons)
Total % 
change 
from 
2003–
2004
Total % 
change 
from 
1998–
2004
Total US 
Agricultural 
Exports to 
the EU
19,565,335.5 18,076,661.9 17,972,788.6 17,694,366.7 16,330,373.2 14,093,206.1 12,540,160.4 -11% - 36%
Soybeans 6,447,288.0 5,393,468.0 6,167,160.0 6,443,726.0 5,981,741.0 4,346,492 3,676,785.0 -15% -43%
Cotton 69,622.0 31,270 42,089 33,138.4 59,425.9 62,428.5 68,227.9 9% - 2%
Maize 331,337.0 164,714 317,300.0 140,189.0 153,939.0 93,541.0 80,384.0 -14% -75%
CHART 1: U.S. AGRICULTURAL EXPORTS TO THE EU–25 BY THE VALUE IN US DOLLARS
1998 1999 2000 2001 2002 2003 2004
Total % 
change 
from 
2003–
2004
Total % 
change 
from 
1998–
2004
Total US 
Agricultural 
Exports to 
the EU
8,205,259 6,832,014 6,483,054 6,630,571 6,338,013 6,659,443 6,810,903 2% -17%
Soybeans 1,534,416 1,032,870 1,154,675 1,159,355 1,168,350 1,113,840 863,121 -22% - 43%
Cotton 115,697 51,388 75,563 56,452 71,526 87,650 94,458 8% - 18%
Maize 36,768 15,053 28,822 12,897 15,141 10,034 8,945 -11% - 75%
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CHART 3: U.S. AGRICULTURAL EXPORTS TO THE EU–25 BY  
PERCENTAGE OF TOTAL U.S. AGRICULTURAL EXPORTS WORLDWIDE
Percentage of  
Total US Agri. 
Exports 1998 1999 2000 2001 2002 2003 2004
Total US 
Agricultural 
Exports to 
the EU
14% 11% 11% 11% 10% 11% 11%
Soybeans 32% 23% 23% 22% 22% 14% 14%
Cotton 4% 4% 3% 2% 3% 2% 2%
Maize 4% 1% 0.1% 0.1% >0.1% >0.1% 0.1%
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APPENDIX C
The WTO Trade Dispute Process
THE WTO DISPUTE SETTLEMENT PROCESS
In the first stage of the WTO dispute process, the aggrieved nations file a formal 
complaint to the WTO and then enter into consultations with the accused nation (or 
party to the WTO), that is believed to have violated WTO rules.16 The consultation 
phase may take up to 60 days to complete, and is intended to provide an opportuni-
ty for the parties to come to agreement without further action.
After 60 days are up, or before if no conclusion has or can be been reached by the 
parties during negotiation, the WTO forms a three person panel called a Dispute 
Settlement Body (DSB) within 45 days of the request for the empanelment by the 
parties to the suit. This panel will hear arguments from the parties to the suit over a 
period of 6–9 months, with 9 months being the maximum time allowed. The DSB 
panelists will adjudicate the dispute, giving both a confidential Interim and Final 
Report to the parties, and then distribute the Final Report and their conclusion to 
the WTO Members. At the end of 60 days from the public issuance of the Final 
Report to the WTO Members, the DSB will adopt the report as final.
If either of the parties disagrees with the decision of the DSB, they may file an 
appeal. The WTO Appellate Body is composed of permanent members and issues a 
second opinion on the DSB report within 90 days. There is no appeal from this deci-
sion. If there is an appeal, the DSB will adopt the decision of the Appellate Body. 
The next stage of the dispute resolution process is the implementation of the ruling. 
The losing party to the suit should remove the illegal measure immediately, but if it 
is impractical to do so, the party is given a “reasonable period of time” either mutu-
ally agreed upon by the parties, or determined through binding arbitration. The ille-
gal measure must, in all cases, be removed within 15 months of the decision. 
If the losing party does not act in compliance with the decision of the dispute reso-
lution process, other countries may withdraw trade concessions and impose retalia-
tory tariffs under the authorization of a DSB. The possibility of retaliation may also 
be arbitrated through the DSB. If there is disagreement on the implementation of the 
16 Submissions to the WTO are available on the WTO website, http://www.wto.org/english/tratop_e/dispu_
e/dispu_e.htm. 
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conclusion, the parties resort to the original DSB panel, which will examine the 
consistency of the implementation of the measures. If the panel finds the losing 
party has indeed conformed the process is completed. If they find that the losing 
party has not implemented the measure in full, retaliatory tariffs and withdrawal 
trade concession may take place as described above.
THE TRADE DISPUTE OVER GMOS
The U.S. trade representatives to the WTO filed a formal complaint against the EU 
with the WTO in May 2003. The suit filed by the U.S. is co-supported by Argentina 
and Canada,17 and has third party support from nine other nations. 
The consultation in this suit took place in Geneva beginning on June 19th, 2003 
and quickly broke down. The delegation from the United States found no chance for 
settlement by negotiation. As soon as the consultation ended, the U.S. delegation 
requested that a Dispute Settlement Body (DSB) be empanelled. 
A Dispute Settlement Body was established and the U.S. and other parties have filed 
briefs on the various issues. By joint request of the parties, the various deadlines 
have been extended in order to give the parties additional times to identify and 
select experts, to prepare additional submissions to the Body, and to consider scien-
tific opinion. The chairman of the dispute settlement Body has indicated that the 
interim confidential report is expected in the first week of January 2006. 
SOURCES FOR APPENDIX C
Office of the United States Trade Representative 
World Trade Organization 
European Union
17 The suit was originally also supported by Egypt, who withdrew from the complaint on May 30, 2003. 
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APPENDIX D
Timeline of events relevant to  
U.S.–EU agricultural biotechnology trade issues
1990–APRIL 
The EU adopts Directive 90/220/EC, which establishes a process for the approval of 
agricultural biotechnology products. 
1994–1998 
The EU authorizes the commercial use of nine GM products and plants. 
1995–MAY 
The U.S. approves the first commercially significant biotech soybean, Monsanto’s 
“Round-up Ready.” 
1996 
Crop varieties developed by biotechnology are first introduced for commercial pro-
duction in the U.S. 
1996–MARCH 20 
Scientific evidence reveals a link between some cases of a variant form of a brain 
wasting disease in humans and consumption of meat from cows with bovine spon-
giform encephalitis (BSE or “mad cow disease”). The British government downplays 
the link and argues that meat is safe to eat. 
1997–FEBRUARY 
Austria bans Novartis Bt176, a GM maize that has already been approved for use in 
the EU. The Commission does not challenge the action. Luxembourg also bans an 
EU-approved maize variety. 
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1997–MAY 15 
The EU adopts the “Novel Foods Regulation,” which requires that the person respon-
sible for placing a novel food, including any food containing or produced from GM 
crops, on the market shall submit a request to the member state in which the prod-
uct will first be marketed. Relevant authorities in that member state then decide 
either to allow the product on the market or to refer the application to the European 
Commission. In either case, the other member states have an opportunity to make 
their views known. The regulation also provides for special labeling of foods con-
taining GM ingredients, provided that the GM content can be detected. The Novel 
Food Regulation included several exemptions for products that did not need to be 
labeled. It also did not define a standard for the percentage of a product that could 
contain GM ingredients before it had to carry the GM label. 
1997–SEPTEMBER 19 
EU regulation provides for labeling of foods processed from certain Bacillus 
thuringiensis (Bt) corn, or corn that has been genetically engineered to produce its 
own insecticide, and herbicide-tolerant soybeans. These products were already on 
the market when the May 1997 novel foods labeling directive went into effect. 
1998 
France bans two EU-approved rapeseed varieties; Greece bans one EU-approved 
rapeseed variety. 
1998–OCTOBER 
Approval of new agricultural biotechnology products in the EU comes to a halt. The 
EU Commission tells the U.S. that they will begin to approve products again if the 
companies submitting applications agree to follow newly proposed revisions before 
they become law. Despite applicant compliance, the EU approval processes does not 
resume. 
1999 
Austria bans two more EU-approved maize varieties. 
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1999–JUNE 
EU members call for a moratorium on new approvals of GM products. The EU 
Environmental Council says traceability and labeling must be linked with a new 
approval process. Ministers from Denmark, France, Greece, Italy, and Luxembourg 
declare a refusal to approve new products until new rules are in place. 
1999–DECEMBER 
The Ministerial Conference of the World Trade Organization (WTO) in Seattle is dis-
rupted by demonstrations by people concerned about continued globalization of 
trade, as well as issues of agriculture and trade in GM foods. The U.S. and Canada 
propose a working group on biotechnology. 
2000 
Italy bans four EU-approved maize varieties; Germany bans one EU-approved maize 
variety. 
2000–JANUARY 11 
The European Commission publishes a regulation providing a one percent labeling 
threshold for food for accidental commingling of corn and soy made by modern 
biotechnology. It is expected that the threshold will be adopted as the basis for 
labeling other foods containing ingredients made from biotechnology. 
2000–JANUARY 29 
More than 130 countries adopt the Cartagena Protocol on Biosafety, aimed at pro-
viding a framework for assessing the environmental impact of bioengineered prod-
ucts that cross international borders. Fifty countries must ratify it before it goes into 
effect. The scope of the protocol does not cover food safety. 
2000–MARCH 
The Codex Ad Hoc Task Force on Foods Derived from Biotechnology has its first 
meeting in Japan. 
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2000–APRIL 
The European Food Standards Agency (EFSA) is created in the EU to “protect public 
heath from risks which may arise in connection with the consumption of food, and 
otherwise to protect the interests of consumers in relation to food.” This includes 
responsibility for issues relating to GM foods. 
2000–JUNE 
French Environmental Minister Dominique Voynet, speaking for the five states who 
voted for a moratorium on GMOs, insists on the inclusion of a liability scheme for 
biotechnology products. 
2000–JULY 
EU Environmental Ministers meet informally and decide to support the moratorium 
at least until the Commission prepares labeling and traceability proposals for bio-
tech products. The Commission tells the U.S. that it will complete the proposals by 
the end of the year so that the approval process could start up again. 
2000–SEPTEMBER 
StarLink® corn—a GM corn variety approved only for animal consumption—is found 
in taco shells sold in the U.S. 
2001–JANUARY 17 
The U.S. Food and Drug Administration (FDA) issues a proposed rule and a 
“Guidance for Industry” document for labeling GM products. The proposed rule 
would require food developers to notify FDA at least four months before putting a 
new GM food on the market, and the scientific description of the product is posted 
on the Internet during this time. The guidance on labeling was meant for manufac-
turers who wish to voluntarily label their foods as being made with or without the 
use of GM ingredients. 
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2001–JUNE 
At the G-8 Economic Summit in Italy, the U.S.-EU Summit includes a special session 
of World Trade Organization (WTO) agriculture negotiations. 
2001–JULY 25 
The European Commission proposes legislation amending Directive 2001/18/EC on 
labeling and traceability and assures the U.S. that the moratorium will be lifted 
within weeks. 
2001–OCTOBER 
At an informal meeting of the Environmental Ministers Council, France, Austria, 
Finland, Luxembourg, Denmark, Italy, the Netherlands, and Sweden all reject the 
Commission’s plan to restart the GMO approval process, and declare the new regula-
tions must be in force before the process should be allowed to operate. 
2002 
The European Food Safety Authority becomes operational. 
2002–MARCH 21 
The Economic and Social Committee issues its opinion on the Commission’s 2001 
proposal on labeling and traceability. 
2002–MAY 16 
The Committee of the Regions issues its opinion on the Commission’s 2001 proposal 
on labeling and traceability. 
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2002–JUNE 3 
The Environment Committee of the European Parliament narrowly voted to require 
all food products derived from biotech ingredients be labeled—even if no remnants 
of the genetic modification (DNA) are detectable in the final product on the shelves. 
In addition, the Committee approved a measure to lower the threshold at which 
mandatory labeling would be required, lowering it from one percent in the original 
EC proposal to 0.5 percent per ingredient. 
2002–AUGUST 27 
The European Union ratifies the Cartagena Protocol on Biosafety. 
2002–SUMMER 
Mid-term report of the Codex Ad Hoc Task Force on Foods Derived From 
Biotechnology is made to the Codex Executive Committee. 
2002–SEPTEMBER 15 
The European Commission resubmits a revised proposal to amend Directive 2001/18/
EC based on the amendments requested by the Parliament’s first reading in June 
2002. 
2002–OCTOBER 17 
Directive 2001/18/EC is implemented and Directive 90/220/EEC is repealed. This 
implementation requires that the 15 member states have all implemented national 
legislation that adopt Directive 2001/18/EC, and have notified the Commission of 
their action. Twelve of the 15 member states fail to meet this deadline, continuing to 
ban new GM products. 
2002–DECEMBER 
The Council of Ministers on the Environment agrees to a common position on trace-
ability and labeling. The Danish delegation declares the moratorium should remain 
in place until the EU has developed and implemented liability legislation for biotech 
products. 
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2003–MARCH 11–14 
The Codex Ad Hoc Task Force on Foods Derived From Biotechnology meets in 
Yokohama, Japan. 
2003–MARCH 17 
The EU Council of Ministers concludes a Common Position on the Commission’s 
September 2002 amendments to its 2001 proposal. The Common Position is for-
warded to the European Parliament. 
2003–APRIL 10 
The European Commission formally requests action to be taken in France, 
Luxembourg, Belgium, Netherlands, Germany, Italy, Ireland, Greece, Spain, Portugal, 
and Austria to adopt and notify the Commission of national legislation that imple-
mented Directive 2001/18/EC. 
2003–MAY 15 
The U.S. files a complaint to the WTO to dispute the EU moratorium on GM imports. 
2003–MAY 20 
The United States’ President Bush accuses the EU of impeding the fight against fam-
ine in Africa, calling the ban on GM foods morally wrong and based on “unscientif-
ic fears.” EU Commissioner on Trade Pascal Lamy answers back that the accusations 
are “unacceptable” and “should not be used in this kind of debate.” 
2003–JUNE 13 
Palau becomes the 50th country to ratify the Cartagena Protocol on Biosafety, per-
mitting it to enter into force in September 2003. 
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2003–JUNE 19 
The United States and EU begin consultation in regards to the WTO suit brought by 
the U.S. The consultations break down shortly after they begin, and the U.S. delega-
tion announces their intent to ask for the empanelment of a WTO Dispute 
Settlement Body. 
2003–JUNE 30–JULY 7 
The 26th Session of the Codex Alimentarius Commission, meets in Rome, Italy. The 
Draft Guideline for the Conduct of Food Safety Assessment of Foods Produced 
Using Recombinant-DNA Microorganisms from the Ad Hoc Committee on Foods 
Derived From Biotechnology is considered. 
2003–JULY 2 
The European Parliament passes the Commission’s September version of the pro-
posed amendments to Directive 2001/18/EC. The United States does not accept the 
action as “lifting the moratorium” and vows to continue its push for more favorable 
laws for its GM products. 
2003–JULY 15 
The European Commission refers Austria, Belgium, Finland, France, Germany, 
Greece, Ireland, Italy, Luxembourg, Netherlands and Spain to the European Court of 
Justice for failing to adopt national legislation implementing Directive 2001/18/EC. 
2003–JULY 22 
The Council of Ministers approves the Commission’s amendments to Directive 
2001/18/EC on labeling and traceability. 
2003–JULY 23 
The European Commission publishes guidelines for the agricultural management of 
“co-existence” or growing GM crops along side non-GM crop varieties.
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2004–APRIL 18
The labeling and traceability measures of 2001/18/EC and related legislation take 
effect in the EU market.
2004–MAY 19
The European Commission authorizes the marketing of canned sweet corn with the 
GM BT-11 trait for 10 years; this is the first GM authorization in the EU since 1998.
2004–MAY
Ten nations from eastern Europe are admitted into the European Union, bringing 
total membership to 25 countries.
2004–JULY
The European Commission authorizes the marketing (but not cultivation) of NK603, 
a Roundup Ready maize.
2005–JANUARY
Hungary invokes the “safeguard clause” to ban MON810 despite EC approval.
2005–FEBRUARY
Commission announces that it will sponsor a broad debate on biotechnology with 
the purpose to clarify the position of the EU-25 on matters related to the deadlock 
on GMO, the WTO case filed against the EU for its moratorium on new GMO 
imports, and the issues relating to “coexistence”.
2005–APRIL
Commission temporarily suspends import of corn and corn products, including corn 
gluten, after Syngenta announces that small quantities of an unapproved GM vari-
ety of maize (Bt10) had inadvertently been released into commercial distribution 
channels over a four-year period.
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2005–APRIL 
EC tells Austria, France, Germany, Greece, and Luxembourg that their invocation of 
the “safeguard” clause to ban approved GMOs is not legitimate and that the bans 
must be lifted, or they will face legal action by the Commission.
2005–JUNE
The Council rejects by a qualified majority the Commission’s proposal to lift the 
bans or restrictions on authorized GMOs adopted by Austria, France, Germany, 
Greece and Luxembourg. This represents the first time the Council mustered a quali-
fied majority either for or against a Commission proposal on GMOs.
2005–AUGUST
The Commission authorizes the import of GM maize MON 863 for use in animal 
feed (but not for cultivation of human food) following the failure of the Council to 
reach a position on the Commission’s proposal in June. 
2005–OCTOBER
The European Court of First Instance, the EU’s second-highest court, rejected an 
appeal by Austria from the Commission’s finding that its ban of an EU-approved 
food was illegal.
SOURCES FOR APPENDIX D 
Office of the United States Trade Representative 
The European Commission 
Codex Alimentaarius Commission 
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APPENDIX E
Backgrounder on the EU
1. WHAT IS THE EUROPEAN UNION? 
The European Union is a supranational institutional framework for the construction 
of a united Europe. It currently consists of 25 member states: Belgium, France, the 
Federal Republic of Germany, Greece, Italy, Luxembourg, the Netherlands, the 
United Kingdom, Ireland, Denmark, Spain, Portugal, Austria, Finland, Sweden, 
Cyprus, the Czech Republic, Estonia, Hungary, Latvia, Lithuania, Malta, Poland, 
Slovakia, and Slovenia. 
The EU has grown from much smaller efforts in the post-World War II period of 
European reconstruction to control economic markets in a small number of coun-
tries, to a political, social, and monetary union through a series of treaties to form 
the EU as it exists—and continues to evolve—today. The EU’s beginnings lie in the 
formation of the European Coal and Steel Community (ECSC) by France, Germany, 
Italy, Belgium, the Netherlands, and Luxembourg in the 1951 Treaty of Paris. Six 
years later, the six ECSC members signed the Treaty of Rome, establishing the 
European Economic Community (EEC), and the European Atomic Energy 
Community (EURATOM). In 1973, the United Kingdom, Ireland, and Denmark joined 
the EEC. 
A European Monetary System was established in 1979 to contain inflation and sta-
bilize exchange rates in Europe. Greece became the tenth member of the EEC in 
1981 and Spain and Portugal acceded in 1986. Also in 1986, the member states 
signed the Single European Act (SEA), which laid the foundations for a single mar-
ket by favoring national regulatory rules. The Treaty on European Union (TEU), also 
called the Maastricht Treaty, was signed in 1991, and set an ambitious plan for the 
12 member states to enter monetary union and eventually come to a single curren-
cy, and to establish a common foreign and security policy. The accession of three 
more countries, Austria, Finland, and Sweden, occurred in 1995. The Treaty of 
Amsterdam in 1997 complemented the TEU on the policies of employment and for-
eign policy. In 1999, Economic and Monetary Union as sought under the TEU 
became a reality, and in 2002, 12 of the member states adopted a common currency, 
the Euro. 
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The framework of the EU was last modified under the Treaty of Nice, which took 
effect on February 1, 2003. The Treaty of Nice, among other changes, ratifies the 
European Commission recommendation that candidate countries Cyprus, the Czech 
Republic, Estonia, Hungary, Latvia, Lithuania, Malta, Poland, the Slovak Republic 
and Slovenia to join the EU. These states joined the EU in May 2004. 
2. DETAILS ON THE EU REGULATORY SYSTEM 
The political and regulatory system of the EU functions through a number of small-
er institutions in which both the national interests of the member states and the 
political interests of the greater Europe are represented. These institutions are the 
European Commission, the Council of Ministers, and the European Parliament. 
THE COMMISSION. The European Commission based in Brussels, Belgium, cur-
rently consists of 25 members, all of whom give up national citizenship to 
become representatives and proponents of the needs of the greater goal of a 
unified Europe acting independently of national governments. The 
Commissioners are appointed by common agreement among the member 
states and are approved as a body by the European Parliament to serve five-
year terms. The current Commission was appointed in 2004 and will serve 
until 2009.
Each Commissioner holds a portfolio or area of expertise in which they pro-
pose policies and legislation. The Commission is responsible for administration 
of EU policies and international trade, and ensures that the provisions of the 
Treaties and the decisions of the institutions are properly implemented. The 
Commission is also the initiator of proposals for legislation. 
THE COUNCIL. The Council of Ministers is composed of ministers representing 
the national governments of the 25 member states. It, along with the European 
Parliament, is the main decision-making institution and final legislative 
authority of the EU. The Council performs this role by enacting legislation 
binding throughout EU territory and directing intergovernmental cooperation. 
Depending on the agenda of a Council meeting, the ministers attending may 
be different. (For example a meeting of the ministers to consider legislation on 
wages would consist of the ministers on labor, a meeting to consider legisla-
tion on agricultural biotechnology and GM products would include the minis-
ters on the environment.) The Presidency of the Council rotates among the 
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member states every six months. At the end of each Presidency there is a 
meeting of the European Council, which is composed of the Heads of State or 
Government of each of the member states. 
The Council of Ministers enacts or rejects legislation by voting in one of two 
ways, unanimity, or qualified majority voting (QMV)(see description below). 
QMV is the most common method of decision-making in the Council of 
Ministers and is used in all but the most sensitive issues. 
THE PARLIAMENT. The process of co-decision allows the European Parliament 
(EP) also to vote on issues that are decided on by the Council of Ministers by 
QMV. Parliament Members are directly elected by the populace of the EU for 
five-year terms. Members of Parliament represent political parties instead of 
national views. The EP is the public forum of the EU where issues of public 
importance are debated and questioning of the Commission and the Council 
takes place. The EP also holds the power to accept or reject most common leg-
islation in the EU by the co-decision process introduced by the Treaty of 
Amsterdam in 1997. 
3. THE LEGISLATIVE PROCESS 
The legislative process is decided by the complex procedure of co-decision. First, the 
Commission proposes a legislative text to the EP for a first reading. The EP adopts a 
position on the proposed legislative text on the basis of a report by its relevant 
standing committee. Then, the EP usually suggests changes to the Commission pro-
posal in the form of amendments. The EP then passes on its revised version of the 
proposed legislative text to the Council of Ministers. The Council either approves 
Parliament’s amendments or modifies them by adopting a common position. If the 
Council approves the Parliament’s amendments without any other modifications, the 
legislation is considered adopted and becomes law. If the Council does not adopt the 
EP’s amendments and takes a common position, the Council passes the proposed 
legislative text back to the EP for a second reading. In the EP, the relevant standing 
committee gives a recommendation to the Parliament to approve, reject, or amend 
the Council’s position. 
At this point, the EP votes and can only approve, reject, or amend the legislation by 
an absolute majority (currently, 367 votes). The Commission then considers the EP’s 
version from its second reading, and forwards an amended proposal to the Council. 
The Council may vote to adopt Parliament’s amendments that have been accepted by 
the Commission by QMV or modify Parliament’s amendments by unanimous vote. 
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If the Council can neither adopt the EP’s second amendments by QMV, nor reject by 
unanimous vote, a conciliation committee is formed and meets for a maximum of 
six weeks. The conciliation committee consists of representatives from both the EP 
and the Council. Usually the EP and Council representatives reach an agreement. 
This agreement takes the form of a joint text. The EP then considers the joint text at 
a third reading and may accept or reject the proposed legislation. If the conciliation 
committee cannot reach agreement, the proposed legislation is considered dead. 
4. THE CONSEQUENCE OF LEGISLATION 
The political institutions work interdependently to create the laws of the EU. EU law 
takes precedence over the national laws of the EU member states under the principle 
of subsidiarity. In general, EU law is composed of three different kinds of legisla-
tion: primary legislation, secondary legislation, and case law. Primary legislation 
includes treaties and other agreements that have been agreed upon by direct negoti-
ation between Member State governments. These treaties and their amendments are 
subject to ratification by the national parliaments of the member states and are 
binding as law in all member states. Secondary legislation is based on the treaties, 
meaning that the treaties make up the legal basis for the legislative action of the 
institutions in the EU regulatory system. 
Secondary legislation is comprised of four different types of rules: regulations, 
directives, decisions, and recommendations/opinions. Regulations are directly appli-
cable and binding in all EU member states without the need for any national imple-
menting legislation. Directives bind member states as to the objectives to be 
achieved within a certain time-limit, but leave the form and means to be used to 
achieve those results up to the national governments. Decisions are binding in all 
their aspects for those to whom they are addressed including any or all member 
states, companies or individuals. Recommendations/opinions are not binding and 
simply express the opinion of the issuing body. Together with case law from the 
European Court of Justice (ECJ), these different types of legislation make up the 
“acquis communautaire” or body of laws to which EU member states and citizens 
must adhere. 
If a Member State does not adhere to a binding law, such as a treaty, regulation or 
directive, the Commission may seek to force that Member State to comply through 
legal action in the European Court of Justice. The ECJ may issue sanctions or penal-
ties against a non-complying party to a binding law. 
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5. QUALIFIED MAJORITY VOTING 
Qualified Majority Voting (QMV) is the most common method for the Council of 
Ministers to make decisions on proposed legislation. Each Member State is assigned 
a certain number of votes. The number of votes each Member State receives are 
weighted depending on the size and population of that Member State. Under the 
Treaty of Nice, there are currently a total of 345 votes held by member states. A 
qualified majority of the current member states is a total of 255 votes as well as a 
majority of member states. In addition, the votes cast must represent 62 percent of 
the total population of Europe.
SOURCES FOR APPENDIX E
The European Commission
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APPENDIX F
Status of GM Crops and Food in the EU
1. APPROVAL OF GM CROPS AND GM FOODS IN THE EU
Under various authorities, a number of GM crops and foods derived from GM crops 
have been approved for food use and marketing in the EU. (Table 1) Some, includ-
ing a GM soy and GM maize variety, were approved for import and processing prior 
to 1998 under Directive 90/220/EEC. More recently, Bt11 sweet corn and NK603 
maize were approved under the amended provisions of the Novel Food Regulation; 
NK603 maize and MON863 maize were also approved under Directive 2001/18. 
Finally, a number of processed foods derived from GM crops, such as canola, corn, 
and cottonseed, are authorized under the “substantially equivalent” notification pro-
visions of Article 5 of the Novel Foods Regulation. 
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TABLE 1: GM FOODS AUTHORIZED IN THE EU UNDER THE NOVEL FOOD REGULATION
Event Crop Applicant Trait Potential Food Uses Date Legal Basis
GTS 40/3/2 Soybean Monsanto Insect pro-
tection and 
herbicide 
tolerance
Soy foods. Soy 
foods include soy 
beverages, tofu, soy 
oil, soy flour, leci-
thin.
03.04.1996 Dir.
90/220/EEC
Art. 13
Bt 176 Maize Ciba-Geigy Insect pro-
tection and 
herbicide 
tolerance
Maize foods. Maize 
foods include ker-
nels, oil, maize 
flour, sugar, syrup.
23.01.1997 Dir.
90/220/EEC
Art. 13
TOPAS 19/2 Oilseed rape AgrEvo Herbicide 
tolerance
Rapeseed oil.
Products made with 
rapeseed oil may 
include fried foods, 
baked products and 
snack foods.
24.06.1997 Reg. (EC)
258/97 
Art. 5
MS1/RF2 Oilseed rape Plant 
Genetic
Systmes
Herbicide 
tolerance
24.06.1997 Reg. (EC)
258/97 
Art. 5
MS1/RF2 Oilseed rape Plant 
Genetic
Systmes
Herbicide 
tolerance
24.06.1997 Reg. (EC)
258/97 
Art. 5
GT 73 Oilseed rape Monsanto Herbicide 
tolerance
21.11.1997 Reg. (EC)
258/97 
Art. 5
MON 810 Maize Monsanto Insect  
protection
Maize derivatives. 
These may include 
maize oil, maize 
flour, sugar and 
syrup. Prodcuts 
made with maize 
derivatives may 
include snack foods, 
baked foods, fried 
foods, confectionary 
and soft drinks.
06.02.1998 Reg. (EC)
258/97 
Art. 5
T 25 Maize AgrEvo Herbicide 
tolerance
06.02.1998 Reg. (EC)
258/97 
Art. 5
Bt 11 Maize Novartis Insect  
protection
06.02.1998 Reg. (EC)
258/97 
Art. 5
MON 809 Maize Pioneer Insect  
protection
23.10.1998 Reg. (EC)
258/97 
Art. 5
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Event Crop Applicant Trait Potential Food Uses Date Legal Basis
Falcon GS
40/90
Oilseed rape Hoechst/
AgrEvo
Herbicide 
tolerance
Rapeseed oil. 
Products made with 
rapeseed oil may 
include fried foods, 
baked foods and 
snack foods
08.11.1999 Reg. (EC)
258/97 
Art. 5
Liberator 
L62
Oilseed rape Hoechst/
AgrEvo
Herbicide 
tolerance
08.11.1999 Reg. (EC)
258/97 
Art. 5
MS8/RF3 Oilseed rape Plant 
Genetic 
Systems
Herbicide 
tolerance
26.04.2000 Reg. (EC)
258/97 
Art. 5
1445 Cotton Monsanto Herbicide 
tolerance
Cottonseed oil. 
Products made with 
cottonseed oil may 
include fried foods, 
baked foods and 
snack foods.
19.12.2002 Reg. (EC)
258/97 
Art. 5
531 Cotton Monsanto Insect  
protection
19.12.2002 Reg. (EC)
258/97 
Art. 5
pRF69/
pRF93
Bacillus  
subtilis
F. 
Hoffmann–
La Roche
Riboflavin Vitamin B2 23.03.2000 Reg. (EC)
258/97 
Art. 5
Bt11 Maize Syngenta Insect resis-
tance
Bt11 Sweet maize 19.05.2004 Reg. (EC)
258/97 
Art. 7
NK603 Maize Monsanto Herbicide 
tolerance
Food and food 
ingredients derived 
from NK603 maize
26.10.2004 Reg. (EC)
258/97 
Art. 7
GM Plants Approved Prior to 1998 under Directive 90/220/EEC
Fourteen GM plants were approved for release or marketing under previous 
Directive 90/220/EEC prior to 1998. The approved plants under Directive 90/220/
EEC included a number of crops: four (4) varieties of maize, four (4) varieties of oil-
seed rape, three (3) varieties of carnation, one (1) variety of chicory, one (1) variety 
of soybean and one (1) variety of tobacco. The GM crops were approved for differ-
ent uses: some for cultivation, some for import and processing, some as food and 
feed. (See Table 2)
These approvals were grandfathered in the repeal of Directive 90/220/EEC and the 
enactment of Directive 2001/18/EC, and therefore the approvals are still effective.
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Additionally, thirteen applications for approval under 90/220/EEC, had received 
favorable opinion of the Scientific Committee on Plants and were pending authori-
zation at the time that the new Directive 2001/18/EC took effect. These applications 
included five varieties of maize/sweet maize, three varieties of oilseed rape, and two 
varieties of cotton, one variety of chicory, and one variety of potato. Some of these 
applications have been resubmitted for consideration under Directive 2001/18/EC 
(see below).
TABLE 2: GMO CROPS APPROVED UNDER DIRECTIVE 90/220/EEC
Product Notifier
Date of Commission 
Decision  
Member State Consent 
Tobacco tolerant to bromoxynil SEITA 
C/F/93/08-02
6/8/1994
Male sterile swede rape resistant to glufos-
inate ammonium (MS1, RF1) 
Uses : breeding activities
Plant Genetic Systems 
C/UK/94/M1/1
2/6/1996
Soybeans tolerant to glyphosate 
Uses : import and processing
Monsanto 
C/UK/94/M3/1
4/3/1996
Male sterile chicory  tolerant to glufosinate 
ammonium 
Uses : breeding activities
Bejo-Zaden BV 
C/NL/94/25
5/20/1996
Bt-maize tolerant to glufosinate ammonium 
(Bt-176)
Ciba-Geigy 
C/F/94/11-03
1/23/1997
Male sterile swede rape tolerant to glufosinate 
ammonium (MS1, RF1) 
Uses : import and processing
Plant Genetic Systems 
C/F/95/05/01/A
6/6/1997 
(not finally approved by 
France)
Male sterile swede rape tolerant to glufosinate 
ammonium (MS1, RF2) 
Plant Genetic Systems 
C/F/95/05/01/B
6/6/1997 
(not finally approved by 
France)
Swede rape tolerant to glufosinate ammonium 
(Topas 19/2) 
Uses : import and processing
AgrEvo 
C/UK/95/M5/1
4/22/1998
Maize tolerant to glufosinate ammonium (T25) AgrEvo 
C/F/95/12/07
4/22/1998
Maize expressing the Bt cryIA(b) gene (MON 
810)
Monsanto 
C/F/95/12-02
4/22/1998
Maize tolerant to glufosinate ammonium and 
expressing the Bt cryIA(b) gene (Bt-11) 
Uses : import and processing
Novartis 
(formerly Northrup King) 
C/UK/96/M4/1
4/22/1998
Source: European Commission (dated 2-16-05)
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Notifications of “Substantially Equivalent” Foods Pursuant  
to Article 5 of Novel Food Regulation (EC) 258/97
A number of food products “derived from” GM crops, such as cooking oils, were 
introduced into the EU market as “substantially equivalent” to conventionally-pro-
duced products under the Novel Food Regulation (EC) 258/97. Table 3 lists the noti-
fications of “substantially equivalent” foods, including those derived from GMOs, 
that have been made pursuant to article 5 of EC 258/97.
TABLE 3: NOTIFICATIONS PURSUANT TO ARTICLE 5  
OF REGULATION (EC) NO 258/97 OF THE EUROPEAN  
PARLIAMENT AND OF THE COUNCIL AS AT JULY 2004
Applicant Description of Food or Food Ingredient Scientific Evidence Notification
Transmission to 
Member States
AgrEvo UK Limited 
Chesterford Park  
Saffron Walden 
UK–Essex CB10 1XL
Processed oil from genetically modified 
canola seed, transformation event 
TOPAS 19/2 and all conventional crossed
“Report on oil from a 
genetically modified (GM) 
glufosinate ammonium 
tolerant oilseed rape” 
(ACNFP)1
9 June 1997 24 June 1997
Plant Genetic  
Systems N.V. 
Jozef Plateaustraat 22 
B–9000 Gent
Processed oil from genetically modified 
oilseed rape seed derived from: i)male 
sterile MS1Bn (B91-4) oilseed rape line 
and all conventional crosses; ii) fertility 
restorer RF2Bn (B94-2) oilseed rape line 
and all conventional crosses; iii) hybrid 
combination MS1XRF2
“Report on oil from a fer-
tility restorer line for use 
in a hybrid breeding pro-
gramme for genetically 
modified (GM) oilseed 
rape” (ACNFP)1
10 June 1997 24 June 1997
again
28 July 1998
Plant Genetic  
Systems N.V. 
Jozef Plateaustraat 22 
B–9000 Gent
Processed oil from genetically modified 
oilseed rape seed derived from: i)male 
sterile MS1Bn (B91-4) oilseed rape line 
and all conventional crosses; ii) fertility 
restorer RF1Bn (B93-101) oilseed rape 
line and all conventional crosses; iii) 
hybrid combination MS1XRF1
“Report on oil from a fer-
tility restorer line for use 
in a hybrid breeding pro-
gramme for genetically 
modified (GM) oilseed 
rape” (ACNFP)1;; and 
“Report on oil from genet-
ically modified oilseed 
rape” (ACNFP)1
10 June 1997 24 June 1997 
again 
28 July 1998
Monsanto Services
International S.A. 
Avenue de Tervuren 
270–272 
B–1150 Brussels
Refined oil from glyphosate tolerant oil-
seed rape line GT73
“Report on oil from genet-
ically modified (GM) 
glyphosate tolerant oil-
seed rape” (ACNFP)1 
10 November 1997 21 November 
1997
Monsanto Services
International S.A. 
Avenue de Tervuren 
270–272 
B–1150 Brussels
Food and food ingredients produced 
from maize flour, maize gluten, maize 
smolina, maize starch, maize glucose, 
and maize oil derived from the progeny 
of maize line MON 810
“Report on processed 
products from genetically 
modifed (GM) insect pro-
tected maize” 
(ACNFP)1
10 December 1997 6 February 1998
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Applicant Description of Food or Food Ingredient Scientific Evidence Notification
Transmission to 
Member States
AgrEvo France S.A. 
Les Algorithmes 
Bátiment Thalés 
Saint Aubin 
F–91197 Gif-sur-Yvette 
Cedex
i) Starch and all its derivatives; ii) crude 
and refined oil; iii) all heat- 
processed or fermented products 
obtained from hominys, grits and flour 
(dry milled fragments) obtained rom the 
genetically modified maize, tolerant to 
glufosinate ammonium, transformation 
event  T25 and all the varieties derived 
from
“Report on processed 
products from genetically 
modified (GM) glufosinate 
ammonium tolerant 
maize” (ACNFP)1
12 January 1998 6 February 1998
Novartis Seeds AG 
Schwarzwaldallee 215 
CH–4058 Basel
Food and food ingredient products 
derived from the original transformant 
Bt11 crossed with the Northrup King 
Company inbred line #2044 (maize), as 
well as from any inbred and hybrid lines 
derived from it and containing the intro-
duced genes
ACNFP1 Report on grain 
from maize genetically 
modifed for insect resis-
tance
30 January 1998 6 February 1998
Pioneer Overseas  
Corporation 
Avenue Tedesco , 7 
B–1160 Brussels
Novel foods and novel food ingredients 
produced from genetically modifed 
maize line MON 809
ACNFP1 Report on geneti-
cally modified (GM) insect 
protected maize Pioneer 
Hi-bred Internationl - line 
MON 809
14 October 1998 23 October 1998
Hoechst Schering, 
AgrEvo GmbH 
Industriepark Hoechst 
AgrEvo-Haus K 607 
D–65926 Fankfurt  
am Main
Processed oil from genetically modified 
oilseed rape derived from Falcon GS 
40/90
BgVV2 Stellungnahme zur 
wesentlichen 
Gleichwertigkeit des aus 
der transgenen, 
Glufosinat-toleranten 
Rapssorte Falcon 
GS/40/90 gewonnenen 
raffinierten Speiseöls
21 October 1999 8/9 November 
1999
Hoechst Schering, 
AgrEvo GmbH 
Industriepark Hoechst 
AgrEvo-Haus K 607 
D–65926 Fankfurt  
am Main
Processed oil from genetically modified 
oilseed rape derived from Liberator L62
BgVV2 Stellungnahme zur 
wesentlichen 
Gleichwertigkeit des aus 
der transgenen, 
Glufosinat-toleranten 
Rapssorte Liberator 
pHoe6/Ac  
gewonnenen raffinierten  
Speiseöls
21 October 1999 8/9 November 
1999
Plant Genetic  
Systems N.V. 
Jozef Plateaustraat 22 
B–9000 Gent
Processed oil from genetically modified 
oilseed rape derived from: the male 
sterile MS8 (DBN 230-0028) oilseed 
rape line and all conventional crosses; 
the fertility restorer RF (DBN212-0005) 
oilseed rape line and all conventional 
crosses; the hybrid combination MS8 x 
RF3
BgVV2 Stellungnahme zur 
wesentlichen 
Gleichwertigkeit des aus 
der transgenen, 
Glufosinat-toleranten 
Rapssorte MS8/RF3 
gewonnenen raffinierten 
Speiseöls
21 October 1999 8/9 November 
1999
F. Hoffman - La Roche 
Ltd. 
Vitamins & Fine  
Chemicals
Regulatory Affairs 
Bldg 241/283 
CH–4070 Basel
Riboflavin from Bacillus subtilis as 
nutrient
ACNFP1 Report on 
Riboflavin from fermen-
tation using genetically 
modified (GM) Bacillus 
subtilis
20 March 2000 26 April 2000
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Applicant Description of Food or Food Ingredient Scientific Evidence Notification
Transmission to 
Member States
Mr. jean-Pierre Clavié 
“Vidalou”
F–47300 Pujols
“Huile d’amandon de pruneau” AFSSA3 Avis relatif à la 
mise sur le marché d’une 
“Huile vierge 
d’amandons de pruneaux
24 July 2000 4 August 2000
Ms. Catherine Drevet 
CD & A sarl 
14 avenue de l’opera 
F–75001 Paris
Huile d’argan (Argania spinosa L.) AFSSA3 Avis relatif à 
l’évaluation de 
l’équivalence en sub-
stance de l’huile d’argan 
(Argania spinosa L.) avec 
d’autres huiles  
alimentaires
23 July 2002 26 August 2002
Dr. Bruno Tinland  
Monsanto Services  
International  
Avenue de Tervuren 
270–272 
B–1150 Brussels
Cottonseed oil from genetically modi-
fied cotton line 1445 (herbicide resis-
tant)
ACNFP1 Request for an 
Article 5 opinion on the 
substantial equivalence 
of cotton seed oil and 
food ingredients derived 
from Roundup® Ready 
cotton
24 July 2002 19 December 
2002
Dr. Bruno Tinland  
Monsanto Services  
International  
Avenue de Tervuren 
270–272 
B–1150 Brussels
Cottonseed oil from genetically modi-
fied cotton line 531 (insect protected)
ACNFP1 Request for an 
Article 5 opinion on the 
substantial equivalence 
of cotton seed oil and 
food ingredients derived 
from insect protected 
cotton
24 July 2002 19 December 
2002
M Jean-Paul Braud 
Innovalg S.A.R.L. 
Centre d’Algoculture 
Polder du Dain 
F–85230 Bouin
Microalga Odontella aurita AFSSA3 Avis de l’Agence 
française de sécurité 
sanitaire des aliments 
relatif à la demande 
d’évaluation de la 
démonstration de 
l’équivalence en sub-
stance d’une microalgue 
Odontella aurita avec des 
algues autorisées
9 December 2002 19 December 
2002
Herr Matthias Werner 
NCT Nord Trading GmbH 
Albert-Schweitzer–Str. 
20 
D–85375 Neufahr b. 
Freising
Juice of the fruits of Morinda citrifolia BVL4 Stellungnahme zur 
Feststellung der wes-
entlichen 
Gleichwertigkeit von Saft 
aus der Frucht der 
Spezies Morinda citrifolia 
L. der Firma NCT Trading 
GmbH mit dem als neuar-
tige Lebensmittelzutat 
zugelassenen „Noni Saft”
10 November 2003 5 December 
2003
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Applicant Description of Food or Food Ingredient Scientific Evidence Notification
Transmission to 
Member States
Drs. René van Lohuizen  
Will  Co. B.V. 
Postbus 46 
NL 1170 AA 
Badhoevedorp 
Dellaertlaan 24 
NL 1171 HG 
Badhoevedorp
Juice of the fruits of Morinda citrifolia See above NCT Nord  
Trading Confirmed by 
Ministerie van 
Volksgezondheid, Welzijn 
en Sport (NL)
22 June 2004 6 July 2004
Poul A Svane 
Svane Trading apS 
Rypevang 4 
DK–3450 Allerod
Juice of the fruits of Morinda citrifolia See above NCT Nord  
Trading Confirmed by 
BVL4 for MfFLoF7 
6 July 2004 16 July 2004
Professor Dr. G.-W.  
von Rymon Lipinski  
Head Regulatory 
Services & Management 
Nutrinova Industriepark 
Höchst
DHA (docohexanoic-acid)-rich microal-
gal oil (DHActive™)
BfR5 Stellungnahme zur 
Feststellung der wes-
entlichen 
Gleichwertigkeit des 
DHA45-Öls mit dem als 
neuartige 
Lebensmittelzutat 
zugelassenen Omega 
Gold™-Öl
10 November 2003 24 December 
2003
Dr. Ernst Karrer 
Paracelsus Haus GmbH 
Freistädter Straße 236 
A–4040 Linz
Noni juice (juice of the fruits of Morinda 
citrifolia)
AGES6 (AT) Antrag auf 
Feststedllung der wes-
entlichen 
Gleichwertigkeit nach 
Art. 3 Abs. 3 VO (EG) Nr. 
258/97 für „Bula Noni® 
Juice 100% Saft aus de 
Frucht der Spezies 
Morinda citrifolia L.” der 
Fa. „Paracelsus Haus 
Handels- und 
Dienstleistungs GmbH” 
als neuartige 
Lebensmittelzutat
23 December 2003 14 January 
2004
Herr Michael Gracher 
GSE–Vertrieb 
Biologische 
Nahrungsergänzungsund 
Heilmittel GmbH 
Saargemünder Str. 18 
D–66119 Saarbrücken
Noni juice (juice of the fruits of Morinda 
citrifolia)
BVL4 (D) Stellungnahme 
zur Feststellung der wes-
entlichen 
Gleichwertigkeit von Saft 
aus der Frucht der 
Spezies Morinda citrifo-
lia L. der Firma GSE-
Vertrieb mit dem als 
neuartige 
Lebensmittelzutat 
zugelassenen „Noni-Saft” 
(Saft aus der Frucht der 
Spezies Morinda citrifolia 
L.) der Fa. Morinda Inc. 
24 December 2003 26 January 
2004
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Applicant Description of Food or Food Ingredient Scientific Evidence Notification
Transmission to 
Member States
Herr Franz Brenner 
Botanical Products 
International 
F.M. Brenner GmbH 
Hauptstrasse 10 
A–2392 
Wienerwald/Grub
Noni juice (juice of the fruits of Morinda 
citrifolia)
AGES6 (AT) Antrag auf 
Feststedllung der wes-
entlichen Gleichwertigkeit 
nach Art. 3 Abs. 3 der VO 
(EG) Nr. 258/97 für ein 
Noni–Saft–Konzentrat der 
Fa. „Botanical Products 
International (BPI) - F.M. 
Brenner GmbH” aus der 
Frucht der Spezies 
Morinda citrifolia L.  
als neuartige 
Lebesmittelzutat
9 January 2004 14 January 2004
Poul A Svane 
Svane Trading apS 
Rypevang 4 
DK–3450 Allerod
Noni juice (juice of the fruits of Morinda 
citrifolia)
MfFLoF7, 
Fødevaredirektoratet (DK) 
–Udtalelse vedrørende 
sammenlignelighed for 
nonisaft produkt fra Pouls 
Svane Trading med det 
godkendte produkt, jf. 
Kommissionens beslut-
ning 2003/426/EF af 5. 
juni 2003 om tilladse til 
markedsforing af nonisaft 
(saft af frugten Morinda  
citrifolia L.) som en ny  
levnesmiddelingrediens 
16 January 2004 6 February 2004
Tahiti Naturel EURL 
PO Box 14968 
Arue–Tahiti 
French Polynesia 
c/o Mme Marysa  
Benjamin  
Tahiti Naturel 
1 Square Xavier 
Monteny 
F–93220 Gagny.
Noni juice (juice of the fruits of Morinda 
citrifolia)
see 22 21 June 2004 29 June 2004
Herr Franz Mitterbauer 
FM Network Marketing 
GmbH 
Stadtplatz 13/1 
A–5280 Braunau
Noni juice (juice of the fruits of Morinda 
citrifolia) with 10% grape juice concen-
trate
AGES6 (AT) Antrag auf 
Feststedllung der wes-
entlichen Gleichwertigkeit 
nach Art. 3 Abs. 4 VO (EG) 
Nr. 258/97 für „Indian 
Noni Indian Mulberry, 
Morinda Saft mit 10% 
Traubensaftkonzentrat” 
der Fa. „FM NETWORK 
MARKETING GMBH”  
als neuartige 
Lebesmittelzutat
1 March 2004 16 March 2004
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Applicant Description of Food or Food Ingredient Scientific Evidence Notification
Transmission to 
Member States
Georg Jessner  
Planta Naturstoffe 
Vertriebsges.m.b.H. 
Erlgasse 48 
A–1120 Wien
Noni juice (juice of the fruits of Morinda 
citrifolia)
AGES6 (AT) Antrag auf 
Feststedllung der wes-
entlichen Gleichwertigkeit 
nach Art. 3 Abs. 4 VO (EG) 
Nr. 258/97 für „Nonivera 
Saft  
(Handelsbezeichnung), 
Bio Noni Saft” der Fa. 
„Planta Naturstoffe 
Vertriebsges.m.b.H.” als 
neuartige  
Lebensmittelzutat
29 March 2004 21 April 2004
Els Deprez 
G.D.I. nv 
Wolvenhovenstraat 12 
B–8870 Izegem
Noni juice (juice of the fruits of Morinda 
citrifolia)
Advies van de Hoge 
Gezondheidsraad (B) 
betreffende de aanvraag 
om erkenning van de 
wezenlijke gelijkwaar-
digheid van een nonisap 
ingediend door de firma 
GDI uit hoofde van artikel 
3(4) van de verordening 
258/97
24 May 2004 6 July 2004
Dr. John Wilkinson
Herbal Sciences  
International Ltd. 
The Seed Bed Centre, 
Langston Road 
UK - Loughton Essex 
IG10 3TQ 
for  
US Nutra 
2751 Nutra Lane 
USA 32726 Eustis FL
Capsules with Astaxanthin-rich 
Carotenoid Oleoresin extracted from 
Haematococcus Pluvialis (max 4 mg 
Astaxanthin/capsule)
ACNFP1 (UK) Request for 
an Article 5 Opinion on 
the Substantial 
Equivalence of 
Astaxanthin-rich 
Carotenoid Oleoresin 
extracted from 
Haematococcus Pluvialis
28 June 2004 13 July 2004
Ms Leena Morander 
Teriaka Ltd. 
Siirakuja 3 
FIN–01490 Vantaa
Milk type products and soya drinks with 
added phytosterols/phytostanols
NFB8 (FIN) Opinion of the 
Novel Food Board on  
substantial equivalence 
in the case of a milk and 
soya drink
1 July 2004 16 July 2004
1 ACNFP Advisory Committee on Novel Foods and Processes (UK) 
2 BgVV Bundesinstitut für gesundheitlichen Verbraucherschutz und Veterinärmedizin (D) 
3 AFFSA Agence française de sécurite sanitaire des alimentes (F) 
4 BVL Bundesamt für Verbraucherschutz und Lebensmittelsicherheit (D) 
5 BfR Bundesinstitut für Risikobewertung (D) 
6 AGES Österreichische Agentur für Gesundheit und Ernährungssicherheit GmbH (A) 
7 MfFLoF  Ministeriet for Fødevarer, Landbrug og Fiskeri (DK) 
8 NFB Novel Food Board (FIN)
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Status of GM plants under Directive 2001/18/EC
In addition to the GM plants authorized under the prior Directive 90/220/EC, the 
Commission has approved two additional GM crops for import and use in feed and 
industrial processing, Monsanto’s Roundup Ready Maize NK603 and Monsanto’s 
MON863, under the new approval process set out in Directive 2001/18/EC.
TABLE 4: GMO PRODUCTS AUTHORISED UNDER DIRECTIVE 2001/18/EC 
 AS OF 24 AUGUST 2005
Product Notifier
Date of Commission Decision 
Member State Consent
Maize Roundup Ready NK603, tolerant 
to glyphosate herbicide 
 
Uses: import and use in feed and indus-
trial processing, not for cultivation
Monsanto 
C/ES/00/01
Commission Decision 2004/643/EC of 
19.07.04 notified under document number 
C(2004)2761
Maize–Zea mays L., line MON 863 - resis-
tant to corn rootworm 
 
Uses: for import and use of grain and 
grain products, not for cultivation
Monsanto 
C/DE/02/9
Commission Decision 2005/608/EC of 
08.08.05 notified under document number 
C(2005)2950
2-16-2005 
Source: European Commission
Pending Applications for Approval under Directive 2001/18/EC
When Directive 2001/18/EC took effect, some of the pending applications from 
under the previous directive, Directive 90/220/EEC were withdrawn, while others 
such as the Bt11 corn were resubmitted, and other new applications were submitted 
for authorization. As of March 2005, twenty-four applications had been submitted 
for approval under Directive 2001/18/EC. These applications included eight (8) vari-
eties of maize, five (5) varieties of oilseed rape, five (5) varieties of cotton, three (3) 
varieties of beets, one (1) variety of potato, one (1) variety of rice, and one (1) vari-
ety of soybean. Seven of these applications were pending under previous Directive 
90/220/EC at the time of its replacement. Some applications request use for import-
ing and processing, while others are requesting cultivation as a permitted use. (See 
Table 5.)
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TABLE 5: GMO PRODUCTS – PENDING NOTIFICATIONS UNDER DIRECTIVE 
2001/18/EC
2/16/2005
Product notification details Company
1.  Maize hybrid MON810 x NK603 (glyphosate-tolerant and containing Bt toxin)
Received by UK under Dir 90/220/EC. (C/GB/02/M3/03) 
Received by the Commission under Dir 2001/18 : 15/01/03
Uses: import and use in feed and industrial processing, not for cultivation.
Monsanto
2.  Oil seed rape – herbicide resistant GT 73
Received by the Netherlands (C/NL/98/11) under Dir 90/220/EC. 
Received by the Commission under Dir 2001/18 : 16/1/03
Uses: import and uses in feed and industrial processing, not for cultivation.
Monsanto
 
3.  Potato with altered starch composition
Received by Sweden (C/SE/96/3501)
Received by the Commission under Dir 90/220: 20.05.98 
Favorable opinion of EU Scientific Committee 18.07.02 
Received by the Commission under Dir 2001/18/EC: 24/01/03
Uses: for cultivation and production of starch, not for use as human food.
AMYLOGENE
HB
4.  Oilseed rape (Ms8, Rf3)
Received by Belgium (C/BE/96/01)
Received by the Commission: under Dir 90/220 16.01.97 
Favorable opinion of EU Scientific Committee 19.05.98 
Received by the Commission under Dir 2001/18: 5/02/03
Uses: import and cultivation in the EU, uses in feed and industrial processing.
Bayer CropScience
5. Maize MON 863 and MON 863 X MON 810 (protection  against certain insect pests)
Received by Germany C/DE/02/9 (6788-01-09) 
Received by the Commission under Dir 2001/18: 7/02/03
Uses: for import and use of grain and grain products, not for cultivation.
Monsanto
6.  Maize herbicide and insect resistant (line 1507 — CRY1F)
Received by the Netherlands (C/NL/00/10) under Dir 90/220/EC. 
Received by the Commission under Dir 2001/18 : 12/02/03
Uses: import and processing, not for cultivation
Pioneer/ 
Mycogen Seeds
7. Maize 1507 (or Bt Cry1F 1507)
Received by Spain (C/ES/01/01) 11/7/2001 under Dir 90/220/EC. 
Received by the Commission under Dir 2001/18: 13/2/03
Uses: import, feed and industrial processing, and cultivation 
Pioneer Hi-Bred /Mycogen 
Seeds
8. Maize tolerant to glufosinate ammonium and expressing the Bt cryIA(b) gene (Bt-11) 
Received by France (C/F/96/05-10) 
Received by the Commission under Dir 90/220: 12.04.99 and 03.05.99 respectively
Favorable opinion of EU Scientific Committee 30.11.00
Received by the Commission under Dir 2001/18/EC: 16.6.2003
Uses: for cultivation, feed and industrial processing
Syngenta Seeds SAS
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Product notification details Company
9.  NK603 Roundup Ready® maize
Received by Spain (C/ES/03/01)
Received by the Commission under Dir 2001/18/EC : 22/07/2003
Uses: import and use in feed and industrial processing, and for cultivation.
Monsanto
10.  Rice tolerant to glufosinate-ammonium, event LLRICE62
Received by UK (C/GB/03/M5/3)
Received by the Commission under Dir 2001/18/EC : 3/9/2003
Uses: import and use in feed and industrial processing, not for cultivation.
Bayer CropScience Ltd
11. NK603 X MON 810 maize 
Received by Spain (C/ES/04/01)
Received by the Commission under Dir 2001/18/EC : 12/1/2004
Uses: import and use in feed and industrial processing, and for cultivation.
Monsanto
12. Cotton (281-24-236/3006-210-23), insect resistant 
Received by Netherlands (C/NL/04/01)
Received by the Commission under Dir 2001/18/EC : 18/2/2004.  Modified SNIF with 
reduced scope received 10/6/2004
Uses: import and use in industrial processing, not for cultivation, not for feed use.
Agrigenetics Inc.
d/b/a Mycogen Seeds,
c/o DowAgroSciences.
13. Carnation (Florigene Moonlite 123.2.38), modified color and herbicide resistant.
Received by Netherlands (C/NL/04/02)
Received by the Commission under Dir 2001/18/EC : 20/9/2004.
Uses: import only, not for cultivation.
Florigene Ltd (Australia)
GM crops Banned by Member State Governments
A number of member states have invoked the “safeguard” clause of Directive 
2001/18/EC and its predecessor law to justify national bans on some GM crops that 
have received European-level approval. As of April, 2005, the Commission has 
informed France, Austria, Luxembourg, Germany, and Greece that they lack scien-
tific justification for those bans and therefore face legal action by the Commission. 
The Commission is still reviewing the more recent invocation of the safeguard 
clause by Hungary. 
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TABLE 6: GM CROPS CURRENTLY BANNED BY MEMBER STATE  
GOVERNMENTS UNDER THE SAFEGUARD CLAUSE
AS OF 15 MARCH 2005
Member State and date of invocation 
Product details and date of Scientific Opinion  
concerning original information to justify bans 
1. FR (20.11.98) Swede rape resistant to glufosinate MS1/RF1 
Uses: cultivation for breeding activities (seed production) 
Product approval: 1996 
Scientific Committee Opinion: 18.05.99 
2. AU (14.02.97) 
3. LX (17.03.97) 
4. DE (28.02.00) 
Bt-maize tolerant to glufosinate ammonium (Bt-176) 
Uses: All uses (cultivation, food and feed, processing) 
Product approval: 1997 
Scientific Committee Opinions: 
21.03., 10.04., 12.05.97 (AU); 09.11.00 (DE) 
EFSA: 08.07.04 (AU)
5. EL (05.11.98) 
6. FR (20.11.98) 
Swede rape tolerant to glufosinate (Topas 19/2) 
Uses: import, storage and processing (no cultivation)
Product approval: 1998
Scientific Committee Opinion: 18.05.99 
EFSA: 08.07.04 (EL)
7. AU (01.06.99) Maize expressing the Bt cryIA(b) gene (MON 810) 
Uses: All uses (cultivation, food and feed, processing) 
Product approval: 1998 
Scientific Committee Opinion: 24.09.99 
EFSA: 08.07.04 
8. AU (08.05.00) Maize tolerant to glufosinate (T25) 
Uses: All uses (cultivation, food and feed, processing)
Product approval: 1998 
Scientific Committee Opinion: 30.11.00 (AU) 
replaced 20.07.01 
EFSA: 08.07.04 
9. HU (20.01.05) Maize expressing the Bt cryIA(b) gene (MON 810) 
Uses: All uses (cultivation, food and feed, processing) 
Product approval: 1998 
Scientific Committee Opinion: 24.09.99 
EFSA: 08.07.04
Source: European Commission  
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2. CULTIVATION OF GM CROPS IN THE EU
Given EU consumer concerns and activist group resistance, including numerous 
incidence of crop vandalism, it is not surprising that few farmers in the EU grow 
approved GM crop varieties. Spain is effectively the only member state in the EU 
that is growing significant amounts of GM crops. In 2004, farmers in Spain planted 
58,000 hectares of Bt maize, an 80% increase from the year before.18 Spain accounts 
for 97% of all GM crops grown in the EU. 
Very small quantities of GM crops are also grown in Germany and France. France 
has reduced the amount of GM crops from about 2,000 hectares in 1998 to less than 
100 hectares in 2004. In 2004, almost 300 hectares were planted to GMO corn in 
Germany. About 100 German farmers registered fields for the planting of GM corn 
(Bt Corn) in 2005. Farmers have indicated intentions to plant nearly 1,000 hectares 
of GMO corn (principally varieties containing the Monsanto trait MON810).
The ten new member states of the EU are not presently cultivating significant quan-
tities of GM crops. Those new States may prove to be more hospitable to GM variet-
ies given the relative lack of political and popular opposition to GM foods and crops 
in the past. Romania, a country waiting for future admission to the EU, currently 
grows about 100,000 hectares of GM soybeans. 
18 Clive James, Global Status of Commercialized Biotech/GM Crops: 2004, ISAAA (2004). 
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GM PLANTINGS IN THE EU 1998-2001 (HECTARES)
1998 1999 2000 2001 2002 2003 2004
France 2,000 1,000 1,000 0 0 0 <100
Portugal 0 1,000 0 0 0 0 0
Spain 20,000 10,000 30,000 30,000 25,000 32,000 32,000
Germany 0 0 1,000 1,000 1,000 1,000 1,000
Total 22,000 11,000 32,000 31,000 26,000 33,000 33,100
Source: European Commission, Directorate-Gneral for Agriculture, World areas sown to GMOs by country
3. EU FIELD TRIALS AND GM CROP RESEARCH 
Though very few GM crops are cultivated commercially in the EU, and few products 
derived from GM crops are on the commercial market, some field trials and testing 
of GM crops and other plants and organisms have been conducted in the EU over 
the past 14 years. However, the pace of field trials has fallen considerably since 
2000. From 1991 to 1999, field trials averaged about 169 a year; from 2000-2004, 
the rate of field trials was about half of that, at about 84 a year. 
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In a recent poll by Fraunhofer ISI, 39 percent of all institutions having projects on 
GM products in the EU have cancelled at least one project in the last four years. The 
poll also found that 21 percent of these institutions cited the unclear legal situation 
as the major factor for canceling their projects. The next highest reasons reported, 
were a feeling of low acceptance for GM products among European consumers 
(19%) and an uncertain market for GM products in the future (17%). The public sec-
tor (23%) was less likely to have cancelled GM research projects than the private 
sector (61%).
Between 1991 and December 2004 there were 1946 notifications of GM field trials 
taking place in the EU. France had the most notifications for field trials with 541, 
accounting for over one-quarter of all trials held. Six other member states held the 
bulk of the other notifications. These six member states, in descending order, were 
Italy (295 notifications), Spain (273 notifications), the United Kingdom (231 notifi-
cations), the Netherlands (151 notifications), and Belgium (130 notifications) and 
Germany (143 notifications). 
These field trials consisted of various GM crops and organisms. The greatest number 
of trials included vegetables and grains (577 trials each), followed by food additive 
crops (421 trials), fruits (120 trials), non-food plants (88 trials), bacteria or viruses 
(83 trials), and trees/flowers (79 trials). Two or more subjects were concurrently test-
ed in 24 of the field trials. 
FIELD TRIALS OF GM IN THE EU BY YEAR
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The most heavily field-tested grain was maize, with 520 trials. The other most test-
ed grains were rice with 33 trials, and wheat with 31 trials. Less tested grains 
included barley (5 trials), alfalfa (2 trials), and rye (1 trial). Grains were combined 
in 17 field trials.
Sugar beets and potatoes were the most tested vegetables with 248 trials and 232 
trials respectively from 1991–December 2004. Fodder beets were the next most 
heavily tested with 29 trials. Soybeans had 17 trials and eggplant 9 trials, lettuce 
had 8 trials, cauliflower and squash had 6 trials each and cabbage had 3 trials. 
Carrot and pumpkin were tested in 3 trials each, while turnips and peas had 2 trials 
each. GM radishes and zucchini each had a single trial. Vegetables were combined 
in 7 trials. 
Tomatoes were the most tested fruit in this period with 75 trials. Melon had 8 trials 
as well as strawberries. Apples were tested in 7 trials, and grapes had 5 trials. Cherry 
and kiwi each had 3 trials, the olive had 2 trials, and orange, plum, raspberry, and 
watermelon each had a single trial. 
Among plants from which food additives are derived, rapeseed was the most tested 
with 368 trials. Chicory was tested 31 times. The rest of the category consisted of 
Indian mustard (3 trials), swede (1 trial), and coffee (1 trial). Among non-food crops, 
tobacco was tested 56 times, and cotton was field tested 33 times from 1991 to 
December 2004.
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